Your session is about to expire
← Back to Search
ProVent-14 Score for Patients on Mechanical Ventilation
N/A
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one-year after participant enrollment
Awards & highlights
Summary
This trial aims to assess whether a specific scoring system, called the ProVent-14 score, can help ICU clinicians make more accurate predictions about the chances of a patient on mechanical ventilation surviving for a year
Who is the study for?
This trial is for ICU day-shift clinicians (attending physicians, fellow physicians, advanced practice providers, or nurses) who are caring for patients needing mechanical ventilation 14-16 days after intubation and not transitioning to comfort-focused care.
What is being tested?
The study tests if ICU clinicians make more accurate one-year mortality predictions when they know a patient's ProVent-14 score—a simple tool that estimates death risk based on conditions at day 14 of mechanical ventilation.
What are the potential side effects?
There are no direct side effects from using the ProVent-14 score as it is a prognostic tool rather than a medical treatment. The focus is on its impact on clinician decision-making.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one-year after participant enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one-year after participant enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accuracy of one-year mortality rate predictions
Secondary outcome measures
Accuracy of timing of patient death
Comfort communicating prognosis to patient/surrogate
Confidence in prediction
+1 moreOther outcome measures
Accuracy of factors influencing prediction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ProVent-14 Guided Prognostic ApproachExperimental Treatment1 Intervention
Participants will be asked to form a prognosis after being provided the patient's ProVent-14 score and its meaning
Group II: Usual Prognostic ApproachActive Control1 Intervention
Participants will make form a prognosis using their usual approach
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
431 Previous Clinical Trials
158,163 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger